GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (BOM:524412) » Definitions » Cyclically Adjusted PS Ratio

Aarey Drugs & Pharmaceuticals (BOM:524412) Cyclically Adjusted PS Ratio : 0.23 (As of Jun. 01, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Cyclically Adjusted PS Ratio?

As of today (2024-06-01), Aarey Drugs & Pharmaceuticals's current share price is ₹46.62. Aarey Drugs & Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₹204.89. Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio for today is 0.23.

The historical rank and industry rank for Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:524412' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.19   Max: 0.31
Current: 0.24

During the past years, Aarey Drugs & Pharmaceuticals's highest Cyclically Adjusted PS Ratio was 0.31. The lowest was 0.11. And the median was 0.19.

BOM:524412's Cyclically Adjusted PS Ratio is ranked better than
92.74% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.085 vs BOM:524412: 0.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Aarey Drugs & Pharmaceuticals's adjusted revenue per share data for the three months ended in Dec. 2023 was ₹30.127. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹204.89 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Aarey Drugs & Pharmaceuticals Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals Cyclically Adjusted PS Ratio Chart

Aarey Drugs & Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.12 0.21 0.12

Aarey Drugs & Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.12 0.16 0.24 0.25

Competitive Comparison of Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.



Aarey Drugs & Pharmaceuticals Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=46.62/204.89
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarey Drugs & Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Aarey Drugs & Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=30.127/152.9243*152.9243
=30.127

Current CPI (Dec. 2023) = 152.9243.

Aarey Drugs & Pharmaceuticals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 21.998 91.425 36.796
201406 20.581 94.103 33.446
201409 29.068 96.780 45.931
201412 31.380 96.780 49.584
201503 45.906 97.163 72.251
201506 25.072 99.841 38.402
201509 19.158 101.753 28.792
201512 37.663 102.901 55.972
201603 60.860 102.518 90.784
201606 55.851 105.961 80.605
201609 48.945 105.961 70.638
201612 54.715 105.196 79.540
201703 67.977 105.196 98.819
201706 40.658 107.109 58.049
201709 34.320 109.021 48.141
201712 44.694 109.404 62.473
201803 58.173 109.786 81.031
201806 28.849 111.317 39.632
201809 30.634 115.142 40.686
201812 33.541 115.142 44.547
201903 58.702 118.202 75.946
201906 28.310 120.880 35.815
201909 27.178 123.175 33.742
201912 25.526 126.235 30.923
202003 47.454 124.705 58.192
202006 10.784 127.000 12.985
202009 21.306 130.118 25.040
202012 40.677 130.889 47.525
202103 75.999 131.771 88.200
202106 41.701 134.084 47.560
202109 57.579 135.847 64.817
202112 55.256 138.161 61.161
202203 59.156 138.822 65.165
202206 46.815 142.347 50.294
202209 30.042 144.661 31.758
202212 24.609 145.763 25.818
202303 61.757 146.865 64.305
202306 20.073 150.280 20.426
202309 22.782 151.492 22.997
202312 30.127 152.924 30.127

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aarey Drugs & Pharmaceuticals  (BOM:524412) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Aarey Drugs & Pharmaceuticals Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarey Drugs & Pharmaceuticals (BOM:524412) Business Description

Traded in Other Exchanges
Address
340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (BOM:524412) Headlines

No Headlines